Floatz logo

9-NITRO-20-(S)-CAMPTOTHECIN

Corpus Uteri

University of New MexicoSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

49 Active assets in the Corpus Uteri cohort.

Asset / SponsorPhaseRating
Carboplatin
City of Hope Medical Center
Phase 3BB
Bms-907351
M.D. Anderson Cancer Center
Phase 2BB
Irinotecan
M.D. Anderson Cancer Center
Phase 2BB
Capivasertib
M.D. Anderson Cancer Center
Phase 2B
Olaparib
National Cancer Institute (NCI)
Phase 2B

View all 50 →

Same molecule, other indications

9-NITRO-20-(S)-CAMPTOTHECIN is also rated in:

cutaneous melanomaDormant
B
Indicative ·
57 / 100
View asset →
renal pelvis/ureter urothelial carcinomaDormant
B
Indicative ·
57 / 100
View asset →
carcinoma of urethraDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →